Topische Kortikosteroid-Monotherapie bei Vogt-Koyanagi-Harada-Syndrom (VKH)

• Literatur

• 1 Lavezzo MM, Sakata VM, Morita C. et al. Vogt-Koyanagi-Harada disease: review of a rare autoimmune disease targeting antigens of melanocytes. Orphanet J Rare Dis 2016; 11: 29
• 2 Yang P, Ye Z, Du L. et al. Novel treatment regimen of Vogt-Koyanagi-Harada disease with a reduced dose of corticosteroids combined with immunosuppressive agents. Curr Eye Res 2018; 43: 254-261
• 3 Yang P, Zhong Y, Du L. et al. Development and evaluation of diagnostic criteria for Vogt-Koyanagi-Harada disease. JAMA Ophthalmol 2018; 136: 1025-1031
• 4 Sakata VM, Da Silva FT, Hirata CE. et al. High rate of clinical recurrence in patients with Vogt-Koyanagi-Harada disease treated with early high-dose corticosteroids. Graefes Arch Clin Exp Ophthalmol 2015; 253: 785-790